Lexicon Pharmaceuticals Inc banner

Lexicon Pharmaceuticals Inc
F:LX31

Watchlist Manager
Lexicon Pharmaceuticals Inc Logo
Lexicon Pharmaceuticals Inc
F:LX31
Watchlist
Price: 2.894 EUR -2.69% Market Closed
Market Cap: €418.1m

Profitability Summary

Lexicon Pharmaceuticals Inc's profitability score is 29/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

29/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

29/100
Profitability
Score
29/100
Profitability
Score

Margins

Earnings Waterfall
Lexicon Pharmaceuticals Inc

Margins Comparison
Lexicon Pharmaceuticals Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Lexicon Pharmaceuticals Inc
NASDAQ:LXRX
703m USD
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
391.5B USD
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
197.4B USD
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
180.2B USD
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
118.4B USD
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80B USD
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
67.8B AUD
Loading...
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
37.7B EUR
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Lexicon Pharmaceuticals Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Lexicon Pharmaceuticals Inc
NASDAQ:LXRX
703m USD
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
391.5B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
197.4B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
180.2B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
118.4B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
67.8B AUD
Loading...
Loading...
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
37.7B EUR
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Lexicon Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett